Sponsor pipeline

Medicines Development for Global Health clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2		1
Phase 3		2

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT07159373	Better Options for Lymphatic Filariasis Treatment	Lymphatic Filariasis	Recruiting	2026-10-07
NCT03876262	Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for…	Onchocerciasis	Active, Not Recruiting	2025-12-23
Phase 2
NCT07172659	Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction	Erythema Nodosum Leprosum	Recruiting	2026-10-06

Get alerts when Medicines Development for Global Health's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.